tiprankstipranks
Sino Biopharmaceutical Ltd (DE:SMZ1)
FRANKFURT:SMZ1
Germany Market
SMZ1
Sino Biopharmaceutical
RESEARCH TOOLSreports

Sino Biopharmaceutical (SMZ1) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

SMZ1 Analyst Ratings

Strong Buy
11Ratings
Strong Buy
11 Buy
0 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Sino
Biopharmaceutical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SMZ1 Stock 12 Month Forecast

Average Price Target

€0.91
▲(53.79% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Sino Biopharmaceutical in the last 3 months. The average price target is €0.91 with a high forecast of €1.18 and a low forecast of €0.76. The average price target represents a 53.79% change from the last price of €0.59.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"€2","-1":"-€1","-0.25":"-€0.25","0.5":"€0.5","1.25":"€1.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1.177308,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€1.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.9073595999999999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€0.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.76307,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€0.76</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.25,0.5,1.25,2],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.545,0.5936390769230769,0.6422781538461539,0.6909172307692308,0.7395563076923077,0.7881953846153846,0.8368344615384615,0.8854735384615385,0.9341126153846154,0.9827516923076923,1.0313907692307693,1.0800298461538462,1.1286689230769231,{"y":1.177308,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.545,0.5728738153846155,0.6007476307692308,0.6286214461538462,0.6564952615384616,0.6843690769230769,0.7122428923076923,0.7401167076923076,0.7679905230769231,0.7958643384615385,0.8237381538461538,0.8516119692307692,0.8794857846153845,{"y":0.9073595999999999,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.545,0.5617746153846154,0.5785492307692308,0.5953238461538461,0.6120984615384616,0.6288730769230769,0.6456476923076924,0.6624223076923077,0.6791969230769231,0.6959715384615385,0.7127461538461539,0.7295207692307693,0.7462953846153846,{"y":0.76307,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.79,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.94,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.862,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.761,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.741,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.671,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.661,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.642,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.676,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.596,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.522,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.483,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.545,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€1.18Average Price Target€0.91Lowest Price Target€0.76
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on DE:SMZ1
Unknown Analyst
Citi
Not Ranked
Citi
€1.09→€1.18
Buy
99.54%
Upside
Reiterated
08/20/26
Sino Biopharmaceutical (SBMFF) Receives a Buy from Citi
CICC Analyst forecast on DE:SMZ1
Unknown Analyst
CICC
Not Ranked
CICC
€0.97
Buy
64.44%
Upside
Reiterated
08/20/26
CICC Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Morgan Stanley Analyst forecast on DE:SMZ1
Alexis Yan
Morgan Stanley
Morgan Stanley
€0.85
Buy
44.11%
Upside
Reiterated
08/19/26
Sino Biopharmaceutical: Strong Profit Beat, Rapid Innovative Franchise Expansion; Buy Rating Reiterated with Unchanged $7.8 Price Target
Daiwa Analyst forecast on DE:SMZ1
Unknown Analyst
Daiwa
Not Ranked
Daiwa
€0.76
Buy
29.33%
Upside
Reiterated
08/12/26
Daiwa Remains a Buy on Sino Biopharmaceutical (SBMFF)
UBS Analyst forecast on DE:SMZ1
Unknown Analyst
UBS
Not Ranked
UBS
€1.2→€0.84
Buy
42.27%
Upside
Reiterated
07/24/26
Sino Biopharmaceutical (SBMFF) Receives a Buy from UBS
Nomura Analyst forecast on DE:SMZ1
Unknown Analyst
Nomura
Not Ranked
Nomura
€0.9
Buy
52.61%
Upside
Reiterated
07/24/26
Nomura Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
UOB Kay Hian Analyst forecast on DE:SMZ1
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€0.78
Buy
33.03%
Upside
Reiterated
07/24/26
Sino Biopharmaceutical (SBMFF) Receives a Buy from UOB Kay Hian
HSBC Analyst forecast on DE:SMZ1
Unknown Analyst
HSBC
Not Ranked
HSBC
€0.93
Buy
57.05%
Upside
Reiterated
07/10/26
HSBC Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
BOCOM International Holdings Company Analyst forecast on DE:SMZ1
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
€0.84
Buy
42.27%
Upside
Reiterated
07/10/26
Sino Biopharmaceutical (SBMFF) Receives a Buy from BOCOM International Holdings Company
CMB International Securities Analyst forecast on DE:SMZ1
Unknown Analyst
CMB International Securities
Not Ranked
CMB International Securities
€0.95
Buy
60.74%
Upside
Reiterated
07/09/26
CMB International Securities Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
Citic Securities Analyst forecast on DE:SMZ1
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€0.98
Buy
66.29%
Upside
Reiterated
06/25/26
DBS Analyst forecast on DE:SMZ1
Mark Kong CFA
DBS
DBS
€0.71
Buy
20.10%
Upside
Initiated
05/20/26
Analysts' Top Healthcare Picks: United Therapeutics (UTHR), Sino Biopharmaceutical (SBMFF)
Jefferies Analyst forecast on DE:SMZ1
Chu Wang
Jefferies
Jefferies
€0.76
Buy
29.33%
Upside
Reiterated
03/30/26
Jefferies Reaffirms Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Bank of America Securities Analyst forecast on DE:SMZ1
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
€0.81
Buy
36.72%
Upside
Reiterated
03/27/26
Bank of America Securities Sticks to Their Buy Rating for Sino Biopharmaceutical (SBMFF)
Bank of China Analyst forecast on DE:SMZ1
Unknown Analyst
Bank of China
Not Ranked
Bank of China
€0.87
Buy
47.81%
Upside
Reiterated
03/27/26
Sino Biopharmaceutical (SBMFF) Gets a Buy from Bank of China
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on DE:SMZ1
Unknown Analyst
Citi
Not Ranked
Citi
€1.09→€1.18
Buy
99.54%
Upside
Reiterated
08/20/26
Sino Biopharmaceutical (SBMFF) Receives a Buy from Citi
CICC Analyst forecast on DE:SMZ1
Unknown Analyst
CICC
Not Ranked
CICC
€0.97
Buy
64.44%
Upside
Reiterated
08/20/26
CICC Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Morgan Stanley Analyst forecast on DE:SMZ1
Alexis Yan
Morgan Stanley
Morgan Stanley
€0.85
Buy
44.11%
Upside
Reiterated
08/19/26
Sino Biopharmaceutical: Strong Profit Beat, Rapid Innovative Franchise Expansion; Buy Rating Reiterated with Unchanged $7.8 Price Target
Daiwa Analyst forecast on DE:SMZ1
Unknown Analyst
Daiwa
Not Ranked
Daiwa
€0.76
Buy
29.33%
Upside
Reiterated
08/12/26
Daiwa Remains a Buy on Sino Biopharmaceutical (SBMFF)
UBS Analyst forecast on DE:SMZ1
Unknown Analyst
UBS
Not Ranked
UBS
€1.2→€0.84
Buy
42.27%
Upside
Reiterated
07/24/26
Sino Biopharmaceutical (SBMFF) Receives a Buy from UBS
Nomura Analyst forecast on DE:SMZ1
Unknown Analyst
Nomura
Not Ranked
Nomura
€0.9
Buy
52.61%
Upside
Reiterated
07/24/26
Nomura Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
UOB Kay Hian Analyst forecast on DE:SMZ1
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€0.78
Buy
33.03%
Upside
Reiterated
07/24/26
Sino Biopharmaceutical (SBMFF) Receives a Buy from UOB Kay Hian
HSBC Analyst forecast on DE:SMZ1
Unknown Analyst
HSBC
Not Ranked
HSBC
€0.93
Buy
57.05%
Upside
Reiterated
07/10/26
HSBC Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
BOCOM International Holdings Company Analyst forecast on DE:SMZ1
Unknown Analyst
BOCOM International Holdings Company
Not Ranked
BOCOM International Holdings Company
€0.84
Buy
42.27%
Upside
Reiterated
07/10/26
Sino Biopharmaceutical (SBMFF) Receives a Buy from BOCOM International Holdings Company
CMB International Securities Analyst forecast on DE:SMZ1
Unknown Analyst
CMB International Securities
Not Ranked
CMB International Securities
€0.95
Buy
60.74%
Upside
Reiterated
07/09/26
CMB International Securities Sticks to Its Buy Rating for Sino Biopharmaceutical (SBMFF)
Citic Securities Analyst forecast on DE:SMZ1
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€0.98
Buy
66.29%
Upside
Reiterated
06/25/26
DBS Analyst forecast on DE:SMZ1
Mark Kong CFA
DBS
DBS
€0.71
Buy
20.10%
Upside
Initiated
05/20/26
Analysts' Top Healthcare Picks: United Therapeutics (UTHR), Sino Biopharmaceutical (SBMFF)
Jefferies Analyst forecast on DE:SMZ1
Chu Wang
Jefferies
Jefferies
€0.76
Buy
29.33%
Upside
Reiterated
03/30/26
Jefferies Reaffirms Their Buy Rating on Sino Biopharmaceutical (SBMFF)
Bank of America Securities Analyst forecast on DE:SMZ1
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
€0.81
Buy
36.72%
Upside
Reiterated
03/27/26
Bank of America Securities Sticks to Their Buy Rating for Sino Biopharmaceutical (SBMFF)
Bank of China Analyst forecast on DE:SMZ1
Unknown Analyst
Bank of China
Not Ranked
Bank of China
€0.87
Buy
47.81%
Upside
Reiterated
03/27/26
Sino Biopharmaceutical (SBMFF) Gets a Buy from Bank of China
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ODTXOdyssey Therapeutics, Inc.
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sino Biopharmaceutical

3 Months
Linda ShuHSBC
Success Rate
3/5 ratings generated profit
60%
Average Return
+11.18%
Copying Linda Shu's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +11.18% per trade.
1 Year
Linda ShuHSBC
Success Rate
3/5 ratings generated profit
60%
Average Return
-0.72%
Copying Linda Shu's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of -0.72% per trade.
2 Years
Linda ShuHSBC
Success Rate
3/5 ratings generated profit
60%
Average Return
+57.46%
Copying Linda Shu's trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +57.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SMZ1 Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
6
7
3
9
11
Buy
4
5
1
3
3
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
12
4
12
14
In the current month, SMZ1 has received 14 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SMZ1 average Analyst price target in the past 3 months is 0.91.
Each month's total comprises the sum of three months' worth of ratings.

SMZ1 Financial Forecast

SMZ1 Earnings Forecast

Next quarter’s earnings estimate for SMZ1 is €0.01 with a range of €0.01 to €0.01. The previous quarter’s EPS was €0.02. SMZ1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SMZ1 has Performed in-line its overall industry.
Next quarter’s earnings estimate for SMZ1 is €0.01 with a range of €0.01 to €0.01. The previous quarter’s EPS was €0.02. SMZ1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year SMZ1 has Performed in-line its overall industry.

SMZ1 Sales Forecast

Next quarter’s sales forecast for SMZ1 is €2.12B with a range of €2.11B to €2.12B. The previous quarter’s sales results were €2.42B. SMZ1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SMZ1 has Performed in-line its overall industry.
Next quarter’s sales forecast for SMZ1 is €2.12B with a range of €2.11B to €2.12B. The previous quarter’s sales results were €2.42B. SMZ1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year SMZ1 has Performed in-line its overall industry.

SMZ1 Stock Forecast FAQ

What is DE:SMZ1’s average 12-month price target, according to analysts?
Based on analyst ratings, Sino Biopharmaceutical Ltd’s 12-month average price target is 0.91.
    What is DE:SMZ1’s upside potential, based on the analysts’ average price target?
    Sino Biopharmaceutical Ltd has 53.79% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sino Biopharmaceutical Ltd a Buy, Sell or Hold?
          Sino Biopharmaceutical Ltd has a consensus rating of Strong Buy, which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Sino Biopharmaceutical Ltd’s share price target?
            The average share price target for Sino Biopharmaceutical Ltd is 0.91. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €1.18 ,and the lowest forecast is €0.76. The average share price target represents 53.79% Increase from the current price of €0.59.
              What do analysts say about Sino Biopharmaceutical Ltd?
              Sino Biopharmaceutical Ltd’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Sino Biopharmaceutical Ltd?
                To buy shares of DE:SMZ1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.